Research output per year
Research output per year
Personal profile
Expertises
Breast cancer; biomarker research
Main research areas
Breast cancer; triple negative breast cancer; neoadjuvant therapy; immunotherapy
Current research
Principal Investigator and national coordinator for the Keynote 173 study. A Phase 1b study evaluating neoadjuvant chemotherapy and immunotherapy for estrogen receptor and HER2 normal breast cancer (Rigshospitalet)
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Christina Annette Bjerre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 2 Journal article
-
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Røssevold, A. H., Andresen, N. K., Bjerre, C. A., Gilje, B., Jakobsen, E. H., Raj, S. X., Falk, R. S., Russnes, H. G., Jahr, T., Mathiesen, R. R., Lømo, J., Garred, Ø., Chauhan, S. K., Lereim, R. R., Dunn, C., Naume, B. & Kyte, J. A., Dec 2022, In: Nature Medicine. 28, 12, p. 2573-2583 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer
Bjerre, C. A., Knoop, A., Bjerre, K., Larsen, M. S., Henriksen, K. L., Lyng, M. B., Ditzel, H. J., Rasmussen, B. B., Brünner, N. A., Ejlertsen, B. & Laenkholm, A-V., Jan 2013, In: Acta oncologica . 52, 1, p. 82-90 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
12 Citations (Scopus)